FDA product code OZG: Transcatheter Septal Occluder (Atrial)
OZG is the FDA product code for transcatheter septal occluder (atrial). It is a Class III device, reviewed by the Cardiovascular panel. Devices under OZG reach the market by PMA; FDA lists no cleared 510(k)s for it. 1 PMA application cites this product code.
Definition
For the treatment of defects in the atrial septum and closure of atrial septal defects via transcatheter technique.
Classification
| Field | Value |
|---|---|
| Device name | Transcatheter Septal Occluder (Atrial) |
| Device class | Class III |
| Review panel | CV — Cardiovascular |
| Medical specialty | Unknown |
| Premarket route | PMA |
| Implant | Yes |
Recalls for OZG devices
FDA recall records list no recalls for product code OZG.
Frequently asked questions
What is FDA product code OZG?
OZG is the FDA product code for transcatheter septal occluder (atrial). It is a Class III device, reviewed by the Cardiovascular panel.
What device class is OZG?
Class III. Typical premarket route: PMA.
Next steps
- Run an FDA pathway report with predicate devices for product code OZG
- Run a recall and safety report across every OZG manufacturer
- Watch product code OZG for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times